Renishaw Diagnostics has launched its first research-use-only (RUO) multiplex assay system, which allows precious research samples to be screened for 10 or more targets from a single sample.
The Rendx RUO multiplex assay system is a novel platform that allows researchers to generate rapid, multiplex screens for their own targets of interest.
Using patented technologies and supported by a team of field- and laboratory-based application specialists, the Rendx RUO system can be configured to support customers' own individual research.
The three-stage process utilises established extraction and amplification platforms, and is fully compatible with standard laboratory techniques and equipment.
This makes the step up to high-sensitivity multiplex detection simple and seamless.
Features: multiplex analysis - up to 10 targets from a single sample; high sensitivity and specificity; rapid analysis; culture independent - analysis direct from the sample; sample matrix independent - simply extract DNA/RNA from any biological sample.
Other applications: clinical research - multiple infectious disease targets in humans and animals; pharmaceutical - biomarkers for antibiotic resistance; food and drink - pathogens, genetically modified ingredients; environmental - water monitoring.
The platform has three components: a reagents kit that contains the materials required to process 100 assays; a purpose-built robotic sample processor with a simple touchscreen interface, designed to allow user-free operation while performing the Rendx assays; and an analyser utilising a highly sensitive form of spectroscopy known as surface-enhanced resonance Raman scattering (SERRS), which performs multiplex detection and automated analysis of a range of samples with a high degree of sensitivity and specificity.
